Literature DB >> 21232910

The infusion of opioids during terminal withdrawal of mechanical ventilation in the medical intensive care unit.

Mark A Mazer1, Chad M Alligood, Qiang Wu.   

Abstract

CONTEXT: Most deaths in intensive care units occur after limitation or withdrawal of life-sustaining therapies. Often these patients require opioids to assuage suffering; yet, little has been documented concerning their use in the medical intensive care unit.
OBJECTIVES: To determine the dose and factors influencing the use of opioids in patients undergoing terminal withdrawal of mechanical ventilation in this setting.
METHODS: Data were prospectively collected from 74 consecutive patients expected to die soon after extubation. The doses of morphine, effect on time to death, and relation of dose to diagnostic categories were analyzed.
RESULTS: The mean (±standard deviation) dose of morphine given to patients during the last hour of mechanical ventilation was 5.3mg/hour. Patients dying after extubation received 10.6 mg/hour just before death. Immediately before extubation, the dose correlated directly with chronic medical opioid use and sepsis with respiratory failure and inversely with coma after cardiopulmonary resuscitation or a primary neurological event. After terminal extubation, the final morphine dose correlated directly with the presence of sepsis with respiratory failure and chronic pulmonary disease. The mean time to death after terminal extubation was 152.7 ± 229.5 minutes without correlation with premorbid diagnoses. After extubation, each 1mg/hour increment of morphine infused during the last hour of life was associated with a delay of death by 7.9 minutes (P = 0.011).
CONCLUSION: Premorbid conditions may influence the dose of morphine given to patients undergoing terminal withdrawal of mechanical ventilation. Higher doses of morphine are associated with a longer time to death.
Copyright © 2011 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21232910     DOI: 10.1016/j.jpainsymman.2010.10.256

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  8 in total

1.  Incidence and Risk Model Development for Severe Tachypnea Following Terminal Extubation.

Authors:  Corey R Fehnel; Miguel Armengol de la Hoz; Leo A Celi; Margaret L Campbell; Khalid Hanafy; Ala Nozari; Douglas B White; Susan L Mitchell
Journal:  Chest       Date:  2020-04-28       Impact factor: 9.410

2.  Guidelines for the withdrawal of life-sustaining measures.

Authors:  James Downar; Jesse W Delaney; Laura Hawryluck; Lisa Kenny
Journal:  Intensive Care Med       Date:  2016-04-08       Impact factor: 17.440

3.  Variable Patterns of Continuous Morphine Infusions at End of Life.

Authors:  Katrina J Lin; Andrea Ching; Kyle P Edmonds; Eric J Roeland; Carolyn Revta; Joseph D Ma; Rabia S Atayee
Journal:  J Palliat Med       Date:  2015-06-24       Impact factor: 2.947

4.  Compassionate extubation for a peaceful death in the setting of a community hospital: a case-series study.

Authors:  Victor C Kok
Journal:  Clin Interv Aging       Date:  2015-04-04       Impact factor: 4.458

Review 5.  Palliative care in intensive care units: why, where, what, who, when, how.

Authors:  Sebastiano Mercadante; Cesare Gregoretti; Andrea Cortegiani
Journal:  BMC Anesthesiol       Date:  2018-08-16       Impact factor: 2.217

6.  Determining the impact of timing and of clinical factors during end-of-life decision-making in potential controlled donation after circulatory death donors.

Authors:  Angela M Kotsopoulos; Nichon E Jansen; Piet Vos; Marloes Witjes; Meint Volbeda; Jelle L Epker; Hans P C Sonneveld; Koen S Simons; Ewald M Bronkhorst; Hans G van der Hoeven; Wilson F Abdo
Journal:  Am J Transplant       Date:  2020-08-26       Impact factor: 8.086

7.  End-of-Life and Palliative Care in a Critical Care Setting: The Crucial Role of the Critical Care Pharmacist.

Authors:  Rhona Sloss; Reena Mehta; Victoria Metaxa
Journal:  Pharmacy (Basel)       Date:  2022-08-31

Review 8.  Pain management during the withholding and withdrawal of life support in critically ill patients at the end-of-life: a systematic review and meta-analysis.

Authors:  Andres Laserna; Alejandro Durán-Crane; María A López-Olivo; John A Cuenca; Cosmo Fowler; Diana Paola Díaz; Yenny R Cardenas; Catherine Urso; Keara O'Connell; Clara Fowler; Kristen J Price; Charles L Sprung; Joseph L Nates
Journal:  Intensive Care Med       Date:  2020-08-24       Impact factor: 17.440

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.